Canopus BioPharma Incorporated Company Review & Valuation

CBIA
OTC Markets
Latest Price
0.05USD

About Canopus BioPharma Incorporated

Canopus BioPharma Incorporated, a pharmaceutical research company, provides pharmaceutical products and assay methods to patients suffering from infectious, cancer, and addiction diseases.

It also provides antivirals, radiation protection products, oncology products, bio-barcode assays, camelidae blood products, and neutraceutricals.

The company was founded in 1996 as Canopus Corporation and changed its name in 2007.

Canopus BioPharma Incorporated is based in Santa Monica, California.

Industry
Drug Manufacturers - Major
HQ Location
Santa Monica, California

Stock Price

Price data not available for Canopus BioPharma Incorporated.

Performance

Please login or create a free account to view the contents of this section.

Financial Reports

Please login or create a free account to view the contents of this section.

Similar Companies

↑back to top

Valuu.io

Valuu provides insights and tools for self-directed stock investors. It enables you to easily find, valuate and track your stock investments with the help of reliable financial data and transparent analysis tools.

Disclaimer: This website is a data portal, which aggregates information about public companies. It is not a stock broker and does not give advice concerning specific investment decisions or tax or legal advice. All data is provided "as-is" with no guarantee for correctness and/or completeness. All company names, logos, and brands are intellectual property of their respective owners. The use of them is for editorial purposes only and does not imply any affiliation or endorsement.
© 2019-2021 Valuu Analytics Sàrl